Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1989 Jun;150(6):668–674.

Hepatitis B in pregnancy.

J A Arevalo
PMCID: PMC1026704  PMID: 2665319

Abstract

Chronic infection with the hepatitis B virus can result in the development of serious liver disease such as chronic active hepatitis, cirrhosis, and hepatocellular carcinoma. Vertical transmission from infected mothers to infants is thought to be partially responsible for the high prevalence of infection in certain high-risk groups. Immunoprophylaxis using hepatitis B vaccine and hepatitis immune globulin has been highly effective in decreasing the probability of chronic hepatitis B virus infection in infants with exposure. Previously, the Centers for Disease Control recommended screening pregnant women considered at high risk of hepatitis B infection to detect newborns who would benefit from postnatal immunizations directed at preventing the HBV carrier state. Because of the poor sensitivity of high-risk criteria in distinguishing pregnant women who harbor the hepatitis B virus, these recommendations have recently been revised to call for the routine screening of all pregnant women in the United States.

Full text

PDF
668

Images in this article

669Image
on p.669

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADAMS R. H., COMBES B. VIRAL HEPATITIS DURING PREGNANCY. JAMA. 1965 Apr 19;192:195–198. doi: 10.1001/jama.1965.03080160015003. [DOI] [PubMed] [Google Scholar]
  2. Albersheim S. G., Smyth J. A., Solimano A., Cook D. Passively acquired human immunodeficiency virus seropositivity in a neonate after hepatitis B immunoglobulin. J Pediatr. 1988 Jun;112(6):915–916. doi: 10.1016/s0022-3476(88)80215-4. [DOI] [PubMed] [Google Scholar]
  3. Arevalo J. A., Washington A. E. Cost-effectiveness of prenatal screening and immunization for hepatitis B virus. JAMA. 1988 Jan 15;259(3):365–369. [PubMed] [Google Scholar]
  4. BLUMBERG B. S., ALTER H. J., VISNICH S. A "NEW" ANTIGEN IN LEUKEMIA SERA. JAMA. 1965 Feb 15;191:541–546. doi: 10.1001/jama.1965.03080070025007. [DOI] [PubMed] [Google Scholar]
  5. Beasley R. P., Hwang L. Y., Lee G. C., Lan C. C., Roan C. H., Huang F. Y., Chen C. L. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983 Nov 12;2(8359):1099–1102. doi: 10.1016/s0140-6736(83)90624-4. [DOI] [PubMed] [Google Scholar]
  6. Beasley R. P., Hwang L. Y., Lin C. C., Stevens C. E., Wang K. Y., Sun T. S., Hsieh F. J., Szmuness W. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial. Lancet. 1981 Aug 22;2(8243):388–393. doi: 10.1016/s0140-6736(81)90832-1. [DOI] [PubMed] [Google Scholar]
  7. Beasley R. P., Hwang L. Y. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis. 1983 Feb;147(2):185–190. doi: 10.1093/infdis/147.2.185. [DOI] [PubMed] [Google Scholar]
  8. Beasley R. P., Hwang L. Y., Stevens C. E., Lin C. C., Hsieh F. J., Wang K. Y., Sun T. S., Szmuness W. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology. 1983 Mar-Apr;3(2):135–141. doi: 10.1002/hep.1840030201. [DOI] [PubMed] [Google Scholar]
  9. Beasley R. P., Stevens C. E., Shiao I. S., Meng H. C. Evidence against breast-feeding as a mechanism for vertical transmission of hepatitis B. Lancet. 1975 Oct 18;2(7938):740–741. doi: 10.1016/s0140-6736(75)90724-2. [DOI] [PubMed] [Google Scholar]
  10. Beasley R. P., Trepo C., Stevens C. E., Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol. 1977 Feb;105(2):94–98. doi: 10.1093/oxfordjournals.aje.a112370. [DOI] [PubMed] [Google Scholar]
  11. Bensabath G., Hadler S. C., Soares M. C., Fields H., Dias L. B., Popper H., Maynard J. E. Hepatitis delta virus infection and Labrea hepatitis. Prevalence and role in fulminant hepatitis in the Amazon Basin. JAMA. 1987 Jul 24;258(4):479–483. doi: 10.1001/jama.1987.03400040077025. [DOI] [PubMed] [Google Scholar]
  12. Brechot C., Pourcel C., Louise A., Rain B., Tiollais P. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature. 1980 Jul 31;286(5772):533–535. doi: 10.1038/286533a0. [DOI] [PubMed] [Google Scholar]
  13. Chen D. S., Sung J. L. Hepatitis B virus infection and chronic liver disease in Taiwan. Acta Hepatogastroenterol (Stuttg) 1978 Dec;25(6):423–430. [PubMed] [Google Scholar]
  14. Cruz A. C., Frentzen B. H., Behnke M. Hepatitis B: a case for prenatal screening of all patients. Am J Obstet Gynecol. 1987 May;156(5):1180–1183. doi: 10.1016/0002-9378(87)90137-2. [DOI] [PubMed] [Google Scholar]
  15. De Cock K. M., Govindarajan S., Valinluck B., Redeker A. G. Hepatitis B virus DNA in fulminant hepatitis B. Ann Intern Med. 1986 Oct;105(4):546–547. doi: 10.7326/0003-4819-105-4-546. [DOI] [PubMed] [Google Scholar]
  16. De Franchis R., D'Arminio A., Vecchi M., Ronchi G., Del Ninno E., Parravicini A., Ferroni P., Zanetti A. R. Chronic asymptomatic HBSAg carriers: histologic abnormalities and diagnostic and prognostic value of serologic markers of the HBV. Gastroenterology. 1980 Sep;79(3):521–527. [PubMed] [Google Scholar]
  17. Delaplane D., Yogev R., Crussi F., Shulman S. T. Fatal hepatitis B in early infancy: the importance of identifying HBsAg-positive pregnant women and providing immunoprophylaxis to their newborns. Pediatrics. 1983 Aug;72(2):176–180. [PubMed] [Google Scholar]
  18. Di Bisceglie A. M., Rustgi V. K., Hoofnagle J. H., Dusheiko G. M., Lotze M. T. NIH conference. Hepatocellular carcinoma. Ann Intern Med. 1988 Mar;108(3):390–401. doi: 10.7326/0003-4819-108-3-390. [DOI] [PubMed] [Google Scholar]
  19. Fawaz K. A., Grady G. F., Kaplan M. M., Gellis S. S. Repetitive maternal-fetal transmission of fatal hepatitis B. N Engl J Med. 1975 Dec 25;293(26):1357–1359. doi: 10.1056/NEJM197512252932608. [DOI] [PubMed] [Google Scholar]
  20. Francis D. P., Hadler S. C., Thompson S. E., Maynard J. E., Ostrow D. G., Altman N., Braff E. H., O'Malley P., Hawkins D., Judson F. N. The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men. Ann Intern Med. 1982 Sep;97(3):362–366. doi: 10.7326/0003-4819-97-3-362. [DOI] [PubMed] [Google Scholar]
  21. Francis D. P., Maynard J. E. The transmission and outcome of hepatitis A, B, and non-A, non-B: a review. Epidemiol Rev. 1979;1:17–31. doi: 10.1093/oxfordjournals.epirev.a036208. [DOI] [PubMed] [Google Scholar]
  22. Friedman S. M., DeSilva L. P., Fox H. E., Bernard G. Hepatitis B screening in a New York City obstetrics service. Am J Public Health. 1988 Mar;78(3):308–310. doi: 10.2105/ajph.78.3.308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Heyward W. L., Lanier A. P., McMahon B. J., Fitzgerald M. A., Kilkenny S., Paprocki T. R. Early detection of primary hepatocellular carcinoma. Screening for primary hepatocellular carcinoma among persons infected with hepatitis B virus. JAMA. 1985 Dec 6;254(21):3052–3054. [PubMed] [Google Scholar]
  24. Jonas M. M., Schiff E. R., O'Sullivan M. J., de Medina M., Reddy K. R., Jeffers L. J., Fayne T., Roach K. C., Steele B. W. Failure of Centers for Disease Control criteria to identify hepatitis B infection in a large municipal obstetrical population. Ann Intern Med. 1987 Sep;107(3):335–337. doi: 10.7326/0003-4819-107-2-335. [DOI] [PubMed] [Google Scholar]
  25. Kattamis C. A., Demetrios D., Matsaniotis N. S. Australia antigen and neonatal hepatitis syndrome. Pediatrics. 1974 Aug;54(2):157–164. [PubMed] [Google Scholar]
  26. Klontz K. C. A program to provide hepatitis B immunoprophylaxis to infants born to HBsAg-positive Asian and Pacific Island women. West J Med. 1987 Feb;146(2):195–199. [PMC free article] [PubMed] [Google Scholar]
  27. Kohler P. F., Dubois R. S., Merrill D. A., Bowes W. A. Prevention of chronic neonatal hepatitis B virus infection with antibody to the hepatitis B surface antigen. N Engl J Med. 1974 Dec 26;291(26):1378–1380. doi: 10.1056/NEJM197412262912603. [DOI] [PubMed] [Google Scholar]
  28. Larouze B., Saimot G., Lustbader E. D., London W. T., Werner B. G., Payet M. Host responses to hepatitis-B infection in patients with primary hepatic carcinoma and their families. A case/control study in Senegal, West Africa. Lancet. 1976 Sep 11;2(7985):534–538. doi: 10.1016/s0140-6736(76)91792-x. [DOI] [PubMed] [Google Scholar]
  29. Lee A. K., Ip H. M., Wong V. C. Mechanisms of maternal-fetal transmission of hepatitis B virus. J Infect Dis. 1978 Nov;138(5):668–671. doi: 10.1093/infdis/138.5.668. [DOI] [PubMed] [Google Scholar]
  30. Lemon S. M., Gates N. L., Simms T. E., Bancroft W. H. IgM antibody to hepatitis B core antigen as a diagnostic parameter of acute infection with hepatitis B virus. J Infect Dis. 1981 Jun;143(6):803–809. doi: 10.1093/infdis/143.6.803. [DOI] [PubMed] [Google Scholar]
  31. Lin H. H., Lee T. Y., Chen D. S., Sung J. L., Ohto H., Etoh T., Kawana T., Mizuno M. Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus. J Pediatr. 1987 Dec;111(6 Pt 1):877–881. doi: 10.1016/s0022-3476(87)80210-x. [DOI] [PubMed] [Google Scholar]
  32. MacNab G. M., Alexander J. J., Lecatsas G., Bey E. M., Urbanowicz J. M. Hepatitis B surface antigen produced by a human hepatoma cell line. Br J Cancer. 1976 Nov;34(5):509–515. doi: 10.1038/bjc.1976.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. McQuillan G. M., Townsend T. R., Johannes C. B., Dillard T., Molteni R. A., Ness P. M., Niebyl J. R. Prevention of perinatal transmission of hepatitis B virus: the sensitivity, specificity, and predictive value of the recommended screening questions to detect high-risk women in an obstetric population. Am J Epidemiol. 1987 Sep;126(3):484–491. doi: 10.1093/oxfordjournals.aje.a114680. [DOI] [PubMed] [Google Scholar]
  34. Okada K., Yamada T., Miyakawa Y., Mayumi M. Hepatitis B surface antigen in the serum of infants after deliver from asymptomatic carrier mothers. J Pediatr. 1975 Sep;87(3):360–363. doi: 10.1016/s0022-3476(75)80635-4. [DOI] [PubMed] [Google Scholar]
  35. STOKES J., Jr, BERK J. E., MALAMUT L. L., DRAKE M. E., BARONDESS J. A., BASHE W. J., WOLMAN I. J., FARQUHAR J. D., BEVAN B., DRUMMOND R. J. The carrier state in viral hepatitis. J Am Med Assoc. 1954 Mar 27;154(13):1059–1065. doi: 10.1001/jama.1954.02940470011003. [DOI] [PubMed] [Google Scholar]
  36. STOKES J., Jr, WOLMAN I. J., BLANCHARD M. C., FARQUHAR J. D. Viral hepatitis in the newborn; clinical features, epidemiology, and pathology. AMA Am J Dis Child. 1951 Aug;82(2):213–216. [PubMed] [Google Scholar]
  37. Sakuma K., Takahara T., Okuda K., Tsuda F., Mayumi M. Prognosis of hepatitis B virus surface antigen carriers in relation to routine liver function tests: a prospective study. Gastroenterology. 1982 Jul;83(1 Pt 1):114–117. [PubMed] [Google Scholar]
  38. Sampliner R. E., Hamilton F. A., Iseri O. A., Tabor E., Boitnott J. The liver histology and frequency of clearance of the hepatitis B surface antigen (HBsAg) in chronic carriers. Am J Med Sci. 1979 Jan-Feb;277(1):17–22. doi: 10.1097/00000441-197901000-00002. [DOI] [PubMed] [Google Scholar]
  39. Schweitzer I. L., Dunn A. E., Peters R. L., Spears R. L. Viral hepatitis b in neonates and infants. Am J Med. 1973 Dec;55(6):762–771. doi: 10.1016/0002-9343(73)90257-x. [DOI] [PubMed] [Google Scholar]
  40. Schweitzer I. L., Spears R. L. Hepatitis-associated antigen (Australia antigen) in mother and infant. N Engl J Med. 1970 Sep 10;283(11):570–572. doi: 10.1056/NEJM197009102831105. [DOI] [PubMed] [Google Scholar]
  41. Schweitzer I. L., Wing A., McPeak C., Spears R. L. Hepatitis and hepatitis-associated antigen in 56 mother-infant pairs. JAMA. 1972 May 22;220(8):1092–1095. [PubMed] [Google Scholar]
  42. Shafritz D. A., Shouval D., Sherman H. I., Hadziyannis S. J., Kew M. C. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. N Engl J Med. 1981 Oct 29;305(18):1067–1073. doi: 10.1056/NEJM198110293051807. [DOI] [PubMed] [Google Scholar]
  43. Sherlock S., Fox R. A., Niazi S. P., Scheuer P. J. Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet. 1970 Jun 13;1(7659):1243–1247. doi: 10.1016/s0140-6736(70)91737-x. [DOI] [PubMed] [Google Scholar]
  44. Shikata T., Karasawa T., Abe K., Uzawa T., Suzuki H., Oda T., Imai M., Mayumi M., Moritsugu Y. Hepatitis B e antigen and infectivity of hepatitis B virus. J Infect Dis. 1977 Oct;136(4):571–576. doi: 10.1093/infdis/136.4.571. [DOI] [PubMed] [Google Scholar]
  45. Shiraki K., Yoshihara N., Sakurai M., Eto T., Kawana T. Acute hepatitis B in infants born to carrier mother with the antibody to hepatitis B e antigen. J Pediatr. 1980 Nov;97(5):768–770. doi: 10.1016/s0022-3476(80)80261-7. [DOI] [PubMed] [Google Scholar]
  46. Sinatra F. R., Shah P., Weissman J. Y., Thomas D. W., Merritt R. J., Tong M. J. Perinatal transmitted acute icteric hepatitis B in infants born to hepatitis B surface antigen-positive and anti-hepatitis Be-positive carrier mothers. Pediatrics. 1982 Oct;70(4):557–559. [PubMed] [Google Scholar]
  47. Stevens C. E., Beasley R. P., Tsui J., Lee W. C. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975 Apr 10;292(15):771–774. doi: 10.1056/NEJM197504102921503. [DOI] [PubMed] [Google Scholar]
  48. Stevens C. E., Taylor P. E., Tong M. J., Toy P. T., Vyas G. N., Nair P. V., Weissman J. Y., Krugman S. Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA. 1987 May 15;257(19):2612–2616. doi: 10.1001/jama.257.19.2612. [DOI] [PubMed] [Google Scholar]
  49. Stevens C. E., Toy P. T., Tong M. J., Taylor P. E., Vyas G. N., Nair P. V., Gudavalli M., Krugman S. Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. JAMA. 1985 Mar 22;253(12):1740–1745. [PubMed] [Google Scholar]
  50. Szmuness W. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol. 1978;24:40–69. [PubMed] [Google Scholar]
  51. Szmuness W., Stevens C. E., Harley E. J., Zang E. A., Alter H. J., Taylor P. E., DeVera A., Chen G. T., Kellner A. Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection. N Engl J Med. 1982 Dec 9;307(24):1481–1486. doi: 10.1056/NEJM198212093072403. [DOI] [PubMed] [Google Scholar]
  52. Tanaka T., Miyamoto H., Hino O., Kitagawa T., Koike M., Iizuka T., Sakamoto H., Ooshima A. Primary hepatocellular carcinoma with hepatitis B virus-DNA integration in a 4-year-old boy. Hum Pathol. 1986 Feb;17(2):202–204. doi: 10.1016/s0046-8177(86)80296-9. [DOI] [PubMed] [Google Scholar]
  53. Tong M. J., Govindarajan S. Primary hepatocellular carcinoma following perinatal transmission of hepatitis B. West J Med. 1988 Feb;148(2):205–208. [PMC free article] [PubMed] [Google Scholar]
  54. Wetzel A. M., Kirz D. S. Routine hepatitis screening in adolescent pregnancies: is it cost effective? Am J Obstet Gynecol. 1987 Jan;156(1):166–169. doi: 10.1016/0002-9378(87)90230-4. [DOI] [PubMed] [Google Scholar]
  55. Wong V. C., Ip H. M., Reesink H. W., Lelie P. N., Reerink-Brongers E. E., Yeung C. Y., Ma H. K. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. Lancet. 1984 Apr 28;1(8383):921–926. doi: 10.1016/s0140-6736(84)92388-2. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES